In addition, multiple studies have also confirmed that SF-1 has a high value in the diagnosis of adrenocortical carcinoma and the prognosis evaluation of patients [21–23], and it has been reported that SF-1 overexpression is associated with a low survival rate in patients with adrenocortical carcinoma. The gene discussed is SF1; the disease is adrenal cortex carcinoma.